Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Skin Neoplasms × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 2 Vulvar Neoplasms 1 Teratoma 1 Skin Neoplasms 1 Seminoma 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neoplasms, Germ Cell and Embryonal 1 Gynecological Cancers 1 Endodermal Sinus Tumor 1 Desmoid Tumors 1 Carcinoma, Embryonal 1

Interventions

pembrolizumab 6 Nivolumab 6 Ipilimumab 6 cemiplimab 4 aldesleukin 3 Blood Specimen Collection 3 fludarabine 2 Specimen Handling 2 Interleukin-2 2 Cyclophosphamide 2 Biopsy 2 trametinib 1 spartalizumab 1 lifileucel 1 fludarabine phosphate 1 dabrafenib 1 brodalumab 1 atezolizumab 1 Tissue Banks 1 Standard of Care 1 Second Harmonic Generation Microscopy 1 Resistance Training 1 Red Light 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Propranolol 1 Pantothenic Acid 1 Observation 1 Nutritional Status 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06647342 2025-01-23

BLESS

Zealand University Hospital

Phase 4 Recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡